Collegium Pharmaceutical (COLL) Notes Payables (2014)
Collegium Pharmaceutical's (COLL) quarterly Notes Payables came in at $5.0 million in Q4 2014.
Collegium Pharmaceutical (COLL) Notes Payables (2014) Analysis & Trends
Collegium Pharmaceutical's Notes Payables history runs 1 years deep, the most recent figure standing at $5.0 million for Q4 2014.
- On a quarterly basis, Notes Payables changed N/A year-over-year to $5.0 million in Q4 2014; TTM through Dec 2014 was $5.0 million, a N/A change from a year earlier, with the FY2014 full-year figure at $5.0 million, changed N/A from the prior year.
- Notes Payables held at $5.0 million in Q4 2014 per COLL's latest filing.
- Across five years, Notes Payables topped out at $5.0 million in Q4 2014 and bottomed at $5.0 million in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Collegium Pharmaceutical | 1.14 Bn | 853.50 Mn | 117.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 5.00 Mn |